Payment Type: | T/T |
---|---|
Min. Order: | 1 Gram |
Model No.: 100429-06-9
Brand: Conbottpharm
Packaging: As required
Productivity: Customized
Transportation: Air
Place of Origin: China
Supply Ability: Commercial
Certificate: Documents Support
Payment Type: T/T
Conbott is offering in wide range of Pharmaceutical Carmoterol Intermediates 5-[(1R)-1-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-8-(phenylmethoxy)-2(1H)-quinolinoneCAS NO.100429-06-9 which is an intermediate of carmoterol. it is an ultra-long-acting beta-adrenoceptor agonist. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking)
These high quality products are formulated by adopting quality methods and using well tested ingredients that are procured from the certified vendors of the market. We offer these products in proper packaging of diverse quantity to meet assorted requirements of the clients.
Thera. Category: Respiratory System Drugs
Cas No.: 100429-06-9
Synonym: 5-[(1R)-1-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-8-(phenylmethoxy)-2(1H)-quinolinone;Carmoterol Intermediate; Intermediate of Intermediate
Molecular Formula: C28H30N2O4
Molecular Weight: 458.5488
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Carmoterol Hydrochloride (TA 2005) CAS 137888-11-0 is chronic obstructive pulmonary disease (COPD)
Related intermeidate:
Carmoterol Hydrochloride 137888-11-0
Carmoterol Intermediate: 5-[(1R)-1-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-8-(phenylmethoxy)-2(1H)-quinolinone 100429-06-9
Product Categories : Process Development